JP2023046323A5 - - Google Patents

Download PDF

Info

Publication number
JP2023046323A5
JP2023046323A5 JP2022151173A JP2022151173A JP2023046323A5 JP 2023046323 A5 JP2023046323 A5 JP 2023046323A5 JP 2022151173 A JP2022151173 A JP 2022151173A JP 2022151173 A JP2022151173 A JP 2022151173A JP 2023046323 A5 JP2023046323 A5 JP 2023046323A5
Authority
JP
Japan
Prior art keywords
oxadiazol
group
alkyl
cycloalkyl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022151173A
Other languages
English (en)
Japanese (ja)
Other versions
JP7653399B2 (ja
JP2023046323A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2023046323A publication Critical patent/JP2023046323A/ja
Publication of JP2023046323A5 publication Critical patent/JP2023046323A5/ja
Application granted granted Critical
Publication of JP7653399B2 publication Critical patent/JP7653399B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022151173A 2021-09-22 2022-09-22 オキサジアゾール誘導体を含有する医薬組成物 Active JP7653399B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021153962 2021-09-22
JP2021153962 2021-09-22

Publications (3)

Publication Number Publication Date
JP2023046323A JP2023046323A (ja) 2023-04-03
JP2023046323A5 true JP2023046323A5 (https=) 2024-03-19
JP7653399B2 JP7653399B2 (ja) 2025-03-28

Family

ID=85777103

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022151173A Active JP7653399B2 (ja) 2021-09-22 2022-09-22 オキサジアゾール誘導体を含有する医薬組成物

Country Status (1)

Country Link
JP (1) JP7653399B2 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK4122923T3 (da) 2020-03-17 2025-12-15 Sumitomo Pharma Co Ltd Oxadiazolderivat

Similar Documents

Publication Publication Date Title
JP2019077725A5 (https=)
US9216972B2 (en) Tricyclic heterocyclic compounds
EP2382212B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
JP2014523400A5 (https=)
US8822510B2 (en) Substituted 3-phenyl-1,2,4-Oxadiazole compounds
JP2012503018A5 (https=)
JP2017537948A5 (https=)
JP2007510689A5 (https=)
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
US8399451B2 (en) Heterocyclic compounds
RU2011153772A (ru) Фторированные аминотриазольные производные
JP2017524026A5 (https=)
EP2635573B1 (en) Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases
JP2010504323A5 (https=)
IL276624B1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases
US8835470B2 (en) Mandelamide heterocyclic compounds
CN1142153C (zh) 苯甲酰哒嗪
FI4122923T3 (fi) Oksadiatsolijohdannainen
JP2023046323A5 (https=)
JPWO2019162702A5 (https=)
JPWO2020249799A5 (https=)
JPWO2021187486A5 (https=)
JPWO2020249785A5 (https=)
JP2005501834A5 (https=)
JPWO2020012423A5 (https=)